Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 7/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225285 | 0.94 | CYP3A4 (0.66) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL4846585 | 0.93 | CYP3A4 (0.57) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL25688075 | 0.93 | CYP3A4 (0.57) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL55328 | 0.93 | CYP3A4 (0.64) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL7218240 | 0.91 | CYP3A4 (0.62) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL19428728 | 0.91 | CYP3A4 (0.54) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL27886570 | 0.89 | CYP3A4 (0.60) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL7224706 | 0.89 | CYP3A4 (0.64) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL28900906 | 0.88 | CYP3A4 (0.58) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL7223059 | 0.88 | CYP3A4 (0.58) | CYP3A4TSHRTDP1ATMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417162-B2 | Oily ingredient for cosmetic preparation and cosmetic preparation | KYOWA YUKA CO., LTD. (JP) | 2008-08-26 | — | — | US | disclosed |
| US-20050130850-A1 | Dibasic acid diesters | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| US-20040219178-A1 | Oily ingredient for cosmetic preparation and cosmetic preparation | KYOWA YUKA CO., LTD. (JP) | 2004-11-04 | — | — | US | disclosed |
| EP-1449823-A1 | DIBASIC ACID DIESTER | Kyowa Yuka Co., Ltd. (JP) | 2004-08-25 | — | — | EP | disclosed |
| EP-1426041-A1 | OILY INGREDIENT FOR COSMETIC PREPARATION AND COSMETIC PREPARATION | Kyowa Yuka Co., Ltd. (JP) | 2004-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219178-A1 | Oily ingredient for cosmetic preparation and cosmetic preparation | DEGS1, DAGLA, LBR | CYP3A4 1514/4885TSHR 2741/4885TDP1 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.